Annual Total Liabilities
$1.24 B
+$118.80 M+10.64%
31 March 2024
Summary:
Haemonetics annual total liabilities is currently $1.24 billion, with the most recent change of +$118.80 million (+10.64%) on 31 March 2024. During the last 3 years, it has risen by +$147.38 million (+13.54%). HAE annual total liabilities is now at all-time high.HAE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$1.65 B
+$10.76 M+0.66%
28 September 2024
Summary:
Haemonetics quarterly total liabilities is currently $1.65 billion, with the most recent change of +$10.76 million (+0.66%) on 28 September 2024. Over the past year, it has increased by +$528.76 million (+47.31%). HAE quarterly total liabilities is now at all-time high.HAE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.6% | +47.3% |
| 3 y3 years | +13.5% | +49.6% |
| 5 y5 years | +103.6% | +171.3% |
HAE Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +13.5% | at high | +56.8% |
| 5 y | 5 years | at high | +103.6% | at high | +174.9% |
| alltime | all time | at high | +2205.3% | at high | +3455.9% |
Haemonetics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.65 B(+0.7%) |
| June 2024 | - | $1.64 B(+32.4%) |
| Mar 2024 | $1.24 B(+10.6%) | - |
| Mar 2024 | - | $1.24 B(-1.7%) |
| Dec 2023 | - | $1.26 B(+12.5%) |
| Sept 2023 | - | $1.12 B(+1.8%) |
| June 2023 | - | $1.10 B(-1.7%) |
| Mar 2023 | $1.12 B(+0.6%) | $1.12 B(+1.3%) |
| Dec 2022 | - | $1.10 B(-3.0%) |
| Sept 2022 | - | $1.14 B(+8.2%) |
| June 2022 | - | $1.05 B(-5.4%) |
| Mar 2022 | $1.11 B(+2.0%) | $1.11 B(+0.9%) |
| Dec 2021 | - | $1.10 B(-0.2%) |
| Sept 2021 | - | $1.10 B(-1.3%) |
| June 2021 | - | $1.12 B(+2.7%) |
| Mar 2021 | $1.09 B(+60.0%) | $1.09 B(+81.7%) |
| Dec 2020 | - | $598.92 M(-20.2%) |
| Sept 2020 | - | $750.25 M(-9.0%) |
| June 2020 | - | $824.60 M(+21.3%) |
| Mar 2020 | $680.00 M(+12.0%) | $680.00 M(+2.5%) |
| Dec 2019 | - | $663.17 M(+9.3%) |
| Sept 2019 | - | $606.79 M(-9.3%) |
| June 2019 | - | $668.64 M(+10.2%) |
| Mar 2019 | $606.90 M(+25.2%) | $606.90 M(+3.8%) |
| Dec 2018 | - | $584.51 M(+3.6%) |
| Sept 2018 | - | $564.37 M(-0.5%) |
| June 2018 | - | $567.11 M(+17.0%) |
| Mar 2018 | $484.91 M(-2.8%) | $484.91 M(-0.8%) |
| Dec 2017 | - | $488.91 M(+4.0%) |
| Sept 2017 | - | $469.91 M(-1.8%) |
| June 2017 | - | $478.61 M(-4.1%) |
| Mar 2017 | $499.10 M(-16.5%) | $499.10 M(-6.8%) |
| Dec 2016 | - | $535.52 M(-8.6%) |
| Sept 2016 | - | $585.71 M(-2.7%) |
| June 2016 | - | $601.83 M(+0.7%) |
| Mar 2016 | $597.56 M(-9.4%) | $597.56 M(-3.1%) |
| Dec 2015 | - | $616.87 M(-3.9%) |
| Sept 2015 | - | $642.06 M(+1.0%) |
| June 2015 | - | $635.76 M(-3.6%) |
| Mar 2015 | $659.29 M(-2.5%) | $659.29 M(+3.0%) |
| Dec 2014 | - | $640.24 M(-2.1%) |
| Sept 2014 | - | $653.83 M(-1.2%) |
| June 2014 | - | $661.66 M(-2.2%) |
| Mar 2014 | $676.29 M(-2.4%) | $676.29 M(+2.1%) |
| Dec 2013 | - | $662.67 M(-3.6%) |
| Sept 2013 | - | $687.77 M(-2.5%) |
| June 2013 | - | $705.25 M(+1.8%) |
| Mar 2013 | $692.74 M(+288.1%) | $692.74 M(-0.4%) |
| Dec 2012 | - | $695.22 M(+1.8%) |
| Sept 2012 | - | $682.59 M(+300.0%) |
| June 2012 | - | $170.66 M(-4.4%) |
| Mar 2012 | $178.50 M(+21.3%) | $178.50 M(+25.2%) |
| Dec 2011 | - | $142.54 M(-2.0%) |
| Sept 2011 | - | $145.44 M(+3.2%) |
| June 2011 | - | $140.95 M(-4.2%) |
| Mar 2011 | $147.13 M(-12.3%) | $147.13 M(+9.1%) |
| Dec 2010 | - | $134.86 M(-5.9%) |
| Sept 2010 | - | $143.34 M(+8.1%) |
| June 2010 | - | $132.64 M(-21.0%) |
| Mar 2010 | $167.80 M(+52.8%) | $167.80 M(+29.9%) |
| Dec 2009 | - | $129.13 M(-4.2%) |
| Sept 2009 | - | $134.86 M(+5.3%) |
| June 2009 | - | $128.09 M(+16.6%) |
| Mar 2009 | $109.81 M(-4.3%) | $109.81 M(+3.0%) |
| Dec 2008 | - | $106.56 M(+2.6%) |
| Sept 2008 | - | $103.89 M(-9.1%) |
| June 2008 | - | $114.30 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | $114.76 M(+23.3%) | $114.76 M(+25.0%) |
| Dec 2007 | - | $91.83 M(-9.0%) |
| Sept 2007 | - | $100.96 M(-0.6%) |
| June 2007 | - | $101.55 M(+9.1%) |
| Mar 2007 | $93.09 M(-11.3%) | $93.09 M(-3.6%) |
| Dec 2006 | - | $96.52 M(-7.6%) |
| Sept 2006 | - | $104.44 M(-1.8%) |
| June 2006 | - | $106.40 M(+1.4%) |
| Mar 2006 | $104.89 M(-6.9%) | $104.89 M(+0.7%) |
| Dec 2005 | - | $104.16 M(-7.0%) |
| Sept 2005 | - | $111.97 M(-1.2%) |
| June 2005 | - | $113.29 M(+0.6%) |
| Mar 2005 | $112.62 M(-11.8%) | $112.62 M(-6.8%) |
| Dec 2004 | - | $120.83 M(+2.5%) |
| Sept 2004 | - | $117.87 M(-3.2%) |
| June 2004 | - | $121.75 M(-4.6%) |
| Mar 2004 | $127.64 M(-6.3%) | $127.64 M(-3.5%) |
| Dec 2003 | - | $132.34 M(-1.6%) |
| Sept 2003 | - | $134.54 M(+0.6%) |
| June 2003 | - | $133.75 M(-1.8%) |
| Mar 2003 | $136.25 M(+6.4%) | $136.25 M(-5.8%) |
| Dec 2002 | - | $144.66 M(+1.5%) |
| Sept 2002 | - | $142.48 M(+4.5%) |
| June 2002 | - | $136.31 M(+6.4%) |
| Mar 2002 | $128.10 M(-1.3%) | $128.10 M(-3.8%) |
| Dec 2001 | - | $133.13 M(-8.0%) |
| Sept 2001 | - | $144.68 M(+7.6%) |
| June 2001 | - | $134.41 M(+3.6%) |
| Mar 2001 | $129.80 M(-1.6%) | $129.80 M(-8.1%) |
| Dec 2000 | - | $141.24 M(+5.8%) |
| Sept 2000 | - | $133.47 M(+3.4%) |
| June 2000 | - | $129.05 M(-2.2%) |
| Mar 2000 | $131.94 M(-1.9%) | $131.94 M(-11.9%) |
| Dec 1999 | - | $149.80 M(+12.1%) |
| Sept 1999 | - | $133.60 M(+6.3%) |
| June 1999 | - | $125.70 M(-6.5%) |
| Mar 1999 | $134.50 M(-5.3%) | $134.50 M(+2.3%) |
| Dec 1998 | - | $131.50 M(-0.5%) |
| Sept 1998 | - | $132.20 M(0.0%) |
| June 1998 | - | $132.20 M(-6.9%) |
| Mar 1998 | $142.00 M(+44.6%) | $142.00 M(+1.2%) |
| Dec 1997 | - | $140.30 M(+3.5%) |
| Sept 1997 | - | $135.50 M(+13.5%) |
| June 1997 | - | $119.40 M(+21.6%) |
| Mar 1997 | $98.20 M(+38.7%) | $98.20 M(+25.3%) |
| Dec 1996 | - | $78.40 M(+6.4%) |
| Sept 1996 | - | $73.70 M(+4.8%) |
| June 1996 | - | $70.30 M(-0.7%) |
| Mar 1996 | $70.80 M(-18.9%) | $70.80 M(-3.7%) |
| Dec 1995 | - | $73.50 M(-12.1%) |
| Sept 1995 | - | $83.60 M(-3.2%) |
| June 1995 | - | $86.40 M(-1.0%) |
| Mar 1995 | $87.30 M(+24.9%) | $87.30 M(+17.7%) |
| Dec 1994 | - | $74.20 M(+2.8%) |
| Sept 1994 | - | $72.20 M(+12.1%) |
| June 1994 | - | $64.40 M(-7.9%) |
| Mar 1994 | $69.90 M(+30.4%) | $69.90 M(+21.8%) |
| Dec 1993 | - | $57.40 M(-1.2%) |
| Sept 1993 | - | $58.10 M(+13.5%) |
| June 1993 | - | $51.20 M(-4.5%) |
| Mar 1993 | $53.60 M(-1.1%) | $53.60 M(+15.5%) |
| Dec 1992 | - | $46.40 M(-7.8%) |
| Sept 1992 | - | $50.30 M(-3.5%) |
| June 1992 | - | $52.10 M(-3.9%) |
| Mar 1992 | $54.20 M | $54.20 M(-12.4%) |
| Dec 1991 | - | $61.90 M(+14.4%) |
| Sept 1991 | - | $54.10 M(+16.8%) |
| June 1991 | - | $46.30 M |
FAQ
- What is Haemonetics annual total liabilities?
- What is the all time high annual total liabilities for Haemonetics?
- What is Haemonetics annual total liabilities year-on-year change?
- What is Haemonetics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Haemonetics?
- What is Haemonetics quarterly total liabilities year-on-year change?
What is Haemonetics annual total liabilities?
The current annual total liabilities of HAE is $1.24 B
What is the all time high annual total liabilities for Haemonetics?
Haemonetics all-time high annual total liabilities is $1.24 B
What is Haemonetics annual total liabilities year-on-year change?
Over the past year, HAE annual total liabilities has changed by +$118.80 M (+10.64%)
What is Haemonetics quarterly total liabilities?
The current quarterly total liabilities of HAE is $1.65 B
What is the all time high quarterly total liabilities for Haemonetics?
Haemonetics all-time high quarterly total liabilities is $1.65 B
What is Haemonetics quarterly total liabilities year-on-year change?
Over the past year, HAE quarterly total liabilities has changed by +$528.76 M (+47.31%)